|
D.I. Trukhan
A comorbid patient at a therapeutic reception during the COVID-19 pandemic. Current aspects of the rehabilitation period
|
№13 / 2022
|
|
I.A. Kurnikova, Sh.G. Gulova, N.O. Danilina, A.S. Klimenko, D.D. Chentsova
Effective treatment of exogenous-constitutional obesity in a young patient: a description of a clinical case
|
№11-12 / 2022
|
|
I.I. Sinitsina (1), A.V. Boyarko (2), I.I. Temirbulatov (1), D.A. Sychev (1)
Effect of CYP2C9 gene polymorphism on losartan dosage regimen in patients with I–II degree arterial hypertension
|
№13 / 2021
|
|
B.G. Iskenderov, N.V. Berenshtein, I.N. Mozhzhukhina
Remodeling of the cardiovascular system in patients with essential arterial hypertension associated with primary subclinical hyperparathyroidism
|
№13 / 2021
|
|
A.F. Verbovoy, Yu.A. Dolgikh
Insulin resistance – a common enemy for endocrinologists and cardiologists
|
№12 / 2021
|
|
A.F. Subkhankulova (1), S.F. Subkhankulova (2)
Women’s health at an elegant age: the possibilities of menopausal hormone therapy
|
№6 / 2021
|
|
D.V. Nebieridze, N.M. Akhmedzhanov, A.S. Safaryan
Current management strategy for high-risk hypertensive patients – focus on lipid-lowering therapy
|
№9 / 2019
|
|
A.E. Bagriy (1), E.S. Mikhailichenko (2), L.I. Kardashevskaya (1), E.V. Shchukina (1)
Potentials for dual RAAS blockade in the correction of endothelial dysfunction in hypertensive patients: comparative study
|
№9 / 2019
|
|
N.V. Korneeva, B.Z. Sirotin
Microcirculation parameters in hypertensive patients who stopped smoking, depending on the duration of smoking cessation
|
№9 / 2019
|
|
A.V. Breus, A.A. Feskova, A.Ya. Kravchenko
Psycho-emotional status and quality of life in patients with arterial hypertension and subclinical hypothyroidism: an observational case-control study
|
№9 / 2019
|
|
M.V. Gorbunova, S.L. Babak, A.G. Malyavin
Long-term compliance with CPAP therapy in patients with obstructive sleep apnea and hypertension
|
№5 / 2019
|
|
T.V. Fofanova, F.T. Ageyev, M.D. Smirnova
LONG-TERM COMPLEX THERAPY OF CARDIOVASCULAR DISEASES (REDUCTION OF CARDIOVASCULAR RISK: HYPOLIDEMIC AND ANTIHYPERTENSIVE THERAPY). COMBINED PREPARATIONS AS A METHOD OF INCREASING TREATMENT ADHERENCE
|
№18 / 2017
|
Русский
